Korean drug makers urged upgrade GMP level

Published: 2010-05-20 06:56:00

Updated: 2010-05-20 06:56:00

Local pharmaceutical firms need to comply with international GMP (good manufacturing practice) as some products are still found to be inappropriate, according to an official at the Korea Food and Drug Administration.

KFDA official Kim Ho-dong said in a seminar that of 331 products screened in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK